COVID-19 and the Future of Our Health Research and Innovation System
Life Sciences Ontario, in collaboration with Shift Health, is convening an online session, “COVID-19 and the Future of Our Health Research and Innovation System” on May 28 from 3:00 to 4:30 pm EDT. Speakers include: Dr. Jim Tartaglia, Vice-President R&D, Global Head of Projects, Sanofi Pasteur; Connie Côté, CEO, Health Charites Coalition of Canada; CIHR’s Institute of Infection and Immunity; Bogi Eliasen, Director of Health, Copenhagen Institute for Futures Studies; and Dr. Ryan Wiley, President, Shift Health. More details are available here. To read “COVID-19 and the Future of Health Research and Innovation”, a recent report published by Shift Health, please click here.
Endowed Chair in Palliative Care Research
The Faculty of Medicine at Dalhousie University is pleased to invite applications for the QEII Foundation Endowed Chair in Palliative Care Research. The successful candidate for the Chair position will engage in palliative care research, as well as... Read More »
The Faculty of Medicine at Dalhousie University is pleased to invite applications for the QEII Foundation Endowed Chair in Palliative Care Research. The successful candidate for the Chair position will engage in palliative care research, as well as... Read More »
Investment in Cancer Research in 2022
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »
Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »